https://ir.lixte.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_a6aa5996494565f9a411e7ae6a5cce0b/lixte/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.lixte.com/news-events/press-releases/detail/150/lixte-biotechnology-announces-16566027-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-strengthening-balance-sheet-for-next-phase-of-strategic-growth Wed, 03 Jun 26 08:30:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/150/lixte-biotechnology-announces-16566027-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-strengthening-balance-sheet-for-next-phase-of-strategic-growth https://ir.lixte.com/news-events/press-releases/detail/149/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors Mon, 01 Jun 26 08:50:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/149/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors https://ir.lixte.com/news-events/press-releases/detail/148/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update Thu, 14 May 26 17:18:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/148/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update https://ir.lixte.com/news-events/press-releases/detail/147/favorable-results-of-ovarian-cancer-study-presented-at-annual-society-of-gynecological-care-conference Mon, 13 Apr 26 08:00:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/147/favorable-results-of-ovarian-cancer-study-presented-at-annual-society-of-gynecological-care-conference https://ir.lixte.com/news-events/press-releases/detail/146/lixte-biotechnology-files-2025-annual-report-on-form-10k-provides-operational-highlights-of-transformative-year Tue, 31 Mar 26 15:45:00 -0400 https://ir.lixte.com/news-events/press-releases/detail/146/lixte-biotechnology-files-2025-annual-report-on-form-10k-provides-operational-highlights-of-transformative-year https://ir.lixte.com/news-events/press-releases/detail/145/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary Wed, 18 Feb 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/145/lixte-biotechnology-appoints-sidney-braun-as-ceo-of-its-liora-technologies-europe-ltd-subsidiary https://ir.lixte.com/news-events/press-releases/detail/144/de-la-soul-led-good-health-summit-launches-february-19-at-morehouse-college Wed, 21 Jan 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/144/de-la-soul-led-good-health-summit-launches-february-19-at-morehouse-college https://ir.lixte.com/news-events/press-releases/detail/143/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29 Tue, 20 Jan 26 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/143/lixte-biotechnology-attending-the-dealflow-discovery-conference-january-28-29 https://ir.lixte.com/news-events/press-releases/detail/142/lixte-and-its-collaborators-expand-clear-cell-ovarian-cancer-trial Tue, 23 Dec 25 08:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/142/lixte-and-its-collaborators-expand-clear-cell-ovarian-cancer-trial https://ir.lixte.com/news-events/press-releases/detail/141/lixte-biotechnology-holdings-inc-announces-4-3-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules Thu, 18 Dec 25 09:00:00 -0500 https://ir.lixte.com/news-events/press-releases/detail/141/lixte-biotechnology-holdings-inc-announces-4-3-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules